(EMAILWIRE.COM, July 20, 2024 ) North America was expected to dominate the market followed by Europe, in 2023 and it is expected to continue during the forecast period. Many key players in North America are working to improve the costly and time-consuming drug discovery process by innovating and adopting organ-on-chip technologies. Significant investments are being made by public and private institutions for research purposes. For Example: The Wyss Institute received nearly USD 5.6 million in grant money from the US FDA to Use its organ-on-chip technology to test human physiological responses to radiation as well as to assess drugs designed to counter radiation effects.
Key Highlights of Organ-On-Chip Market:
The Organ-On-Chip Market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study.
Request For Free Sample Report : https://www.maximizemarketresearch.com/request-sample/29364/
Global Organ-On-Chip Market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation.
Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Global Organ-On-Chip Market are also profiled.
Organ-On-Chip Market Segmentation:
By offering:
Services
Products
Request For Free Sample Report : https://www.maximizemarketresearch.com/request-sample/29364/
By Type:
Liver-on-Chip
Lung-on-Chip
Kidney-on-Chip
Heart-on-Chip
Intestine-on-Chip
Brain-on-Chip
Others
By Application:
Toxicology Research
Physiological Model Development
Drug Discovery
By End-User:
Pharmaceutical & Biotechnology
Companies
Academic Research Institutes
Others
Request For Free Sample Report : https://www.maximizemarketresearch.com/request-sample/29364/
Key Players of Organ-On-Chip Market:
Emulate Inc.
TissUse GmbH
Kirkstall Ltd.
CN Bio Innovations Ltd
Ascendance Biotechnology, Inc.
Nortis, Inc.
Mimetas B.V.
Hurel Corporation
Organovo Holdings, Inc.
CN Innovations Holdings Limited
Axosim Technologies LLC
Insphero Ag
Hesperos Inc
Tara Biosystems
SynVivo
Maximize Market Research is leading Medical Devices research firm, has also published the following reports:
Vertigo Treatment Market size was valued at USD 1.68 Bn in 2023 and the market is expected to grow at a CAGR of 4.63%.
Minimal Residual Disease Testing Market size was valued at USD 1.60 Bn. in 2023 and the market revenue is expected to grow at a CAGR of 12.8%.
About Maximize Market Research
Maximize Market Research provides B2B and B2C research on 6,500 high-growth emerging opportunities and technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics and communications, Internet of Things, Food and Beverages, Aerospace and defense, and other manufacturing sectors.
